We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
-3.18%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.57B
AUM Growth
-$118M
Cap. Flow
-$42.5M
Cap. Flow %
-2.71%
Top 10 Hldgs %
17.86%
Holding
854
New
57
Increased
321
Reduced
405
Closed
55
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMCR icon
326
Amcor
AMCR
$21.9B
$1.13M 0.07%
24,767
+62
+0.3% +$2.99K
CION icon
327
CION Investment
CION
$372M
$1.13M 0.07%
107,263
+51,939
+94% +$562K
TW icon
328
Tradeweb Markets
TW
$22B
$1.13M 0.07%
14,065
+6,453
+85% +$514K
DGII icon
329
Digi International
DGII
$3.17B
$1.12M 0.07%
41,498
+1,707
+4% +$58.7K
URI icon
330
United Rentals
URI
$71.2B
$1.12M 0.07%
2,517
+1,355
+117% +$620K
AVY icon
331
Avery Dennison
AVY
$13.6B
$1.12M 0.07%
6,119
+374
+7% +$67.7K
PNI
332
PIMCO New York Municipal Income Fund II
PNI
$78M
$1.11M 0.07%
173,286
-28,981
-14% -$211K
PPL
333
PPL Corp
PPL
$26.5B
$1.11M 0.07%
47,135
-2,498
-5% -$64.6K
VGT icon
334
Vanguard Information Technology ETF
VGT
$147B
$1.11M 0.07%
21,392
+408
+2% +$22.2K
VBF icon
335
Invesco Bond Fund
VBF
$168M
$1.11M 0.07%
76,517
-1,268
-2% -$18.8K
PFE icon
336
Pfizer
PFE
$152B
$1.1M 0.07%
33,233
+9,223
+38% +$326K
SKX
337
DELISTED
Skechers
SKX
$1.1M 0.07%
22,452
+11,409
+103% +$583K
ROST icon
338
Ross Stores
ROST
$80.8B
$1.1M 0.07%
9,720
+3,504
+56% +$402K
UPBD icon
339
Upbound Group
UPBD
$1.11B
$1.09M 0.07%
37,154
+2,889
+8% +$90.1K
CORT icon
340
Corcept Therapeutics
CORT
$12.1B
$1.09M 0.07%
40,107
+6,756
+20% +$196K
CBAY
341
DELISTED
Cymabay Therapeutics
CBAY
$1.09M 0.07%
72,839
+34,403
+90% +$456K
JPS
342
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$1.08M 0.07%
174,779
+7,149
+4% +$45.5K
SEAT icon
343
Vivid Seats
SEAT
$84.4M
$1.08M 0.07%
8,377
-87
-1% -$12.8K
SQM icon
344
Sociedad Química y Minera de Chile
SQM
$20.6B
$1.07M 0.07%
17,905
+1,140
+7% +$76.9K
OPK icon
345
Opko Health
OPK
$1.04B
$1.07M 0.07%
667,520
+40,100
+6% +$73K
YUM icon
346
Yum! Brands
YUM
$39.5B
$1.06M 0.07%
8,454
-693
-8% -$91.2K
TGTX icon
347
TG Therapeutics
TGTX
$7.64B
$1.05M 0.07%
126,186
-3,570
-3% -$49.8K
ARWR icon
348
Arrowhead Research
ARWR
$12.6B
$1.05M 0.07%
39,159
+2,276
+6% +$69.7K
MFM
349
Aberdeen Municipal Income Fund
MFM
$222M
$1.05M 0.07%
+230,286
New +$1.16M
SSTK icon
350
Shutterstock
SSTK
$200M
$1.04M 0.07%
27,389
-5,803
-17% -$260K

Similar funds

Hennion & Walsh Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Hennion & Walsh Asset Management held 854 positions worth $1.57B, down 7% from $1.69B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Hennion & Walsh Asset Management's Q3 2023 filing shows 57 new, 321 increased, 405 reduced and 55 closed positions. Its largest new stake was WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund: 474,056 shares worth $19.5M. The largest sale was Schwab US Dividend Equity ETF, an estimated $20.5M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Financials and Technology.

  • Hennion & Walsh Asset Management's largest Q3 2023 buy was WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund: 474,056 shares worth $19.5M.
  • Hennion & Walsh Asset Management added most to Nuveen Municipal Credit Income Fund in Q3 2023, an estimated $2.51M increase.
  • Hennion & Walsh Asset Management's biggest Q3 2023 reduction was Schwab US Dividend Equity ETF, cutting an estimated $20.5M.
  • Hennion & Walsh Asset Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $4.42M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 18% of its $1.57B portfolio in Q3 2023.
  • Hennion & Walsh Asset Management opened 57 new positions and closed 55 in Q3 2023.
  • Hennion & Walsh Asset Management's portfolio value fell 7% quarter-over-quarter to $1.57B.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2023, filed 27 Oct 2023.